VERU INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3
VERU INC. (VERU) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 of $0 for the 12-month period ending 2021-09-30, per its 10-K filed 2021-12-02.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 · last filed 2021-12-02
- VERU INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2020-09-30 was $0.00.
- VERU INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2020-06-30 was $0.00.
- VERU INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2020-03-31 was $0.00.
- VERU INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2019-12-31 was $0.00.
- VERU INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2021 was $0.00.
- VERU INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2020 was $0.00.
- VERU INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2019 was $0.00.
- VERU INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2018 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 10-K · filed 2021-12-02 | |||
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-02 | $0.00 derived: sum of 2 quarters · filed 2021-12-02 | $0.00 derived: sum of 3 quarters · filed 2021-12-02 | $0.00 10-K · filed 2021-12-02 |
| 2020-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-13 | $0.00 derived: sum of 2 quarters · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 | $0.00 derived: sum of 4 quarters · filed 2020-12-10 |
| 2020-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-13 | $0.00 10-Q · filed 2020-05-13 | $0.00 derived: sum of 3 quarters · filed 2020-12-10 | $0.00 derived: sum of 4 quarters · filed 2020-12-10 |
| 2019-12-31 | $0.00 10-Q · filed 2020-02-12 | $0.00 derived: sum of 2 quarters · filed 2020-12-10 | $0.00 derived: sum of 3 quarters · filed 2020-12-10 | $0.00 derived: sum of 4 quarters · filed 2020-12-10 |
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-10 | $0.00 derived: sum of 2 quarters · filed 2020-12-10 | $0.00 derived: sum of 3 quarters · filed 2020-12-10 | $0.00 10-K · filed 2020-12-10 |
| 2019-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-13 | $0.00 derived: sum of 2 quarters · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 | $0.00 derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-13 | $0.00 10-Q · filed 2020-05-13 | $0.00 derived: sum of 3 quarters · filed 2020-05-13 | $0.00 derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $0.00 10-Q · filed 2020-02-12 | $0.00 derived: sum of 2 quarters · filed 2020-02-12 | $0.00 derived: sum of 3 quarters · filed 2020-02-12 | |
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-13 | $0.00 derived: sum of 2 quarters · filed 2019-08-08 | $0.00 10-K · filed 2018-12-13 | |
| 2018-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |